Purdue Allotted 10 Days For Ch. 11 Confirmation Trial
OxyContin maker Purdue Pharma's Chapter 11 plan confirmation trial will be limited to 10 days, after a New York bankruptcy judge said Monday that objectors to the plan had requested far...To view the full article, register now.
Already a subscriber? Click here to view full article